Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03155100
Brief Title: Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines (KEd)

First Submitted : May 14, 2017
First Submitted that Met QC Criteria : May 14, 2017
First Posted : May 16, 2017

Last Update Submitted that Met QC Criteria : January 6, 2019
Last Update Posted : January 8, 2019